Matthias Huber

Dr. Matthias Huber is a Zurich-based investment professional who co-founded and helps lead Verium AG, an independent multi-family office that partners with entrepreneurial families to preserve and grow wealth across generations. He has been associated with Verium since its founding (2011) and serves as a Partner in Wealth Management and Head of the firm's Investment Committee, overseeing asset allocation and direct private-equity investments.

Earlier in his career, Huber was Investment Manager and Chief Investment Officer (CIO) at Chemolio Management Ltd., where he was responsible for private-equity direct investments, board representation, and the design and implementation of an integrated investment strategy. Chemolio is a Swiss family-linked investment group; Chemolio Holding AG (Zurich, founded 1956) and Chemolio Industrie Holding AG (Hünenberg, founded 2006) operate as participation/industrial holdings. Huber remains connected to this group as Vice Chairman / board member of Chemolio Industrie Holding AG, which is the basis of his chemolio.ch email address.

Before his private-equity work, Huber was a Project Manager in Corporate Finance at Bank Vontobel, working on IPOs, M&A transactions, bond issues, and secondary transactions. He holds a doctorate (Dr. oec. publ.) from the University of Zurich and is a Chartered Financial Analyst (CFA) charterholder.

He currently sits on the boards (Verwaltungsrat) of several companies, including Exalos, Reliva, Flaschenpost, Sulzer Schmid Labs, and Chemolio Industrie Holding, reflecting a hands-on, board-level approach to the companies in which he and his firm invest.

• Invests primarily through Verium's direct-investment platform in established, profitable Swiss/DACH companies rather than early-stage venture — targeting businesses that are cash-flow positive with EBITDA above ~CHF 2 million.
• Seeks "sustainable, transformative and asset-light" businesses with "strong management teams" and "clear competitive advantages." (Verium's stated direct-investment criteria.)
• Focuses on structural growth trends: technology, outsourcing, healthcare, and environmental transformation.
• Prefers founder-led growth stories, buy-and-build platforms, and succession solutions, taking majority or significant-minority stakes with equity tickets from ~CHF 9 million at the firm level.
• The stub classification as an "Angel Investor" doing Seed Rounds is only partially borne out by public sources — his documented activity is board-level PE investing, with at least one seed-stage deal (Lynus, 2024); direct personal angel check sizes are not publicly disclosed.